ELRIG UK

Take a peek at the scientific tracks at our upcoming Protein Sciences 2024 Conference. Here's what we have in store: 🧫 Day 1 – November 18th Track 1: Generation of antigens for drug discovery Chaired by Katie Smith (GSK) & Ben Kemp (Agenus), this track explores innovative approaches to antigen design—vital in advancing therapeutic antibodies and vaccines. Track 2: Protein biophysics at different stages of drug discovery.  Dive into the biophysical insights that drive drug discovery with Laura Itzhaki (University of Cambridge) & Shane Chandler (GSK), exploring breakthrough methods to decode complex targets and drug mechanisms. 🧬 Day 2 – November 19th Track 1: High-throughput in silico and experimental approaches to accelerate protein generation. Learn how high-throughput and in silico approaches are speeding up protein design, chaired by Lovisa Holmberg-Schiavone (AZ) & James Love (Novo Nordisk). Track 2: Cryo-EM in Drug Discovery: From protein to structure to dynamics. Discover the power of cryo-EM in visualizing protein structures to unlock new therapeutic possibilities with track chairs Vanita Sood (Fable Therapeutics) & @Radoslav Enchev (Francis Crick Institute). Register now to join our track chairs and speakers: https://lnkd.in/d47_6wXC

Join academics and industry leaders as we discuss the latest advancements in metabolic disease. 5 November 2024 - 9am - 4:30pm BioInnovation Institute, Denmark Free-to-attend!   Register now: https://lnkd.in/ewyaywYX Focusing on how data generated through cutting-edge tools (such as genetics, proteomics, metabolomics, transcriptomics, single-cell spatial metabolomics, and single-cell nuclei transcriptomics, along with in vivo imaging) are revolutionising our understanding of disease progression, diagnosis, and treatment efficacy. And dive into how identifying novel obesity targets through genetic analysis provides insights into the mode of action of a new drug modality. Birgitte Andersen Ariel Feldstein Rupa Shree Appa-Pind Louise Strandberg Clemmensen Saleha Patel DefiniGEN Novo Nordisk BioInnovation Institute

𝗖𝗮𝗹𝗹 𝘁𝗼 𝗷𝗼𝗶𝗻 𝗘𝗟𝗥𝗜𝗚’𝘀 𝗕𝗼𝗮𝗿𝗱 𝗮𝘀 𝗼𝘂𝗿 𝗘𝗻𝗴𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝘆 𝗟𝗲𝗮𝗱𝗲𝗿!   With the term of our dedicated board member, Chris Williams, coming to an end, we’re excited to invite applications for a new lead of ELRIG’s Engagement Strategy Work Group. This pivotal role ensures ELRIG remains relevant and accessible, as we drive growth in our community of life science professionals. If you have a passion for or expertise in marketing and communications and would like to volunteer your skills on ELRIG’s Board, we welcome your application! Apply here: https://lnkd.in/exJZU3Dg   Position Title ELRIG Board Member and Chair of Engagement Strategy Work Group   𝗞𝗲𝘆 𝗥𝗲𝘀𝗽𝗼𝗻𝘀𝗶𝗯𝗶𝗹𝗶𝘁𝗶𝗲𝘀: - Shape the strategic direction for ELRIG’s marketing and community engagement function, representing this direction at monthly board meetings. - Work closely with ELRIG’s Marketing and Communications Manager and CEO to implement that direction. - Ensure that ELRIG has a cohesive digital content strategy including a strong social media presence, and productive media partnerships. - Champion diverse community perspectives, especially accessibility and inclusivity across digital platforms and content. - Contribute to other ELRIG business areas as needed.   This opportunity is open primarily to members of ELRIG’s General Committee, but we welcome expressions of interest from others passionate about making an impact. 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝗰𝗹𝗼𝘀𝗲 𝗼𝗻 𝘁𝗵𝗲 𝟮𝟵𝘁𝗵 𝗼𝗳 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟮𝟬𝟮𝟰.   Join us in driving ELRIG’s vision forward!

Are you sharing a poster at Protein Sciences 2025? Don't forgot you could apply for a travel bursary... applications close TOMORROW! Don't delay, there are limited funds. https://lnkd.in/gpqj6tEN

📢 We are delighted to announce our fantastic Conference Directors Sarah Brockbank and Roger Clark are back to lead the scientific content for Research & Innovation 2025 AND 𝐫𝐞𝐠𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐢𝐬 𝐧𝐨𝐰 𝐎𝐏𝐄𝐍! https://lnkd.in/eKwMJNM3 This is event is free-to-attend, as usual, with no hidden membership fees! 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 & 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝟮𝟬𝟮𝟱: 𝗕𝗶𝗴 𝗺𝗼𝗹𝗲𝗰𝘂𝗹𝗲𝘀 𝘁𝗼 𝗯𝗶𝗴 𝗱𝗮𝘁𝗮... 𝘁𝗵𝗶𝗻𝗸𝗶𝗻𝗴 𝗯𝗶𝗴 𝘁𝗼 𝗱𝗿𝗶𝘃𝗲 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵. Royal Society of Medicine, London 10-11 March This conference will discusses how emerging biology and cutting-edge technologies are pioneering the medicines of tomorrow. Bringing together scientists, researchers and entrepreneurs with bold ideas to serve our shared ambitions in creating the next generation of therapeutics to cure more patients around the world. Reserve your ticket now! Royal Society of Medicine #researchandinnovation #elrig #ELRIGRI2025

We’re delighted to invite you to our Drug Discovery forum in Paris to discuss the latest advancements in single cell genomics. 𝗥𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗳𝗿𝗲𝗲 - https://lnkd.in/enEA8GuS There are no hidden membership costs Join us on 3rd December at Institut Imagine, Paris with our Forum Directors Thomas Edmonds and Jarrod Walsh Event Overview: 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗙𝗼𝗿𝘂𝗺 𝗣𝗮𝗿𝗶𝘀 – 𝗦𝗶𝗻𝗴𝗹𝗲 𝗖𝗲𝗹𝗹 𝗚𝗲𝗻𝗼𝗺𝗶𝗰𝘀 The human body is composed of trillions of cells containing nearly identical genomes. However, the myriad of controlling factors that govern genomic regulation mean they can take on unique and distinct states and roles. Abnormalities in the genomes or the factors that control their behaviour can result in heterogeneity of cell populations and contribute to disease states. The maturation of single-cell technologies is making it increasingly possible to interrogate this heterogeneity and tease apart the resulting molecular mechanisms that drive disease phenotypes. This Forum will explore the latest research enabling single-cell genomics technologies and the impacts they are contributing in our understanding and treatment of disease. We are delighted to bring you this event within partnership with ELRIGfr - Association d’experts pour la robotique de laboratoire FORUM PARTNER: Hamilton Company If you have any questions about this event please pop them in the comments below and if you think you know anyone who might be interested in joining us there, please tag them. Thank you #singlecellgenomics #ELRIG #drugdiscovery

Kirsty Smitten won the Early Career Professional Impact Award at Research & Innovation 2021 for her pioneering work on antimicrobial compounds. In honour of her remarkable contributions and inspiring spirit, we’ve renamed our ECP Impact Award to the "Kirsty Smitten Award." Kirsty was a strong proponent of self-improvement, and was keen to inspire others to seize opportunities for personal growth. We hope this award inspires early career professionals to follow in her footsteps and carry on her legacy.

Feel the excitement of Drug Discovery 2024 all over again with our event photos! The energy was electric, and we’re so grateful to have such a supportive, vibrant community. Can you spot yourself in the action? View more Drug Discovery 2024 photos here: https://lnkd.in/enQb9NP5

𝗣𝗥𝗢𝗧𝗘𝗜𝗡 𝗦𝗖𝗜𝗘𝗡𝗖𝗘𝗦 𝟮𝟬𝟮𝟱 https://lnkd.in/gA6BTU_s 𝗣𝗢𝗦𝗧𝗘𝗥 𝗗𝗘𝗔𝗗𝗟𝗜𝗡𝗘: General posters 3rd November. PLUS find out more about our travel bursary open to poster presenters UK and ROW.𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝗰𝗹𝗼𝘀𝗲 𝘁𝗵𝗶𝘀 𝗙𝗿𝗶𝗱𝗮𝘆 𝟮5t𝗵 𝗢𝗰𝘁. https://lnkd.in/e9mza2qB The Protein Society #proteinsciences24 #elrig #drugdiscovery Conference Directors Lovisa Holmberg-Schiavone Kate Smith Laura Itzhaki Vanita Sood Theresia Schaedler

You are invited to join us in Copenhagen next month... as our free-to-attend Forum: Drug Discovery in Denmark takes place. Register free https://lnkd.in/ewyaywYX Topic - ADVANCING HUMAN-CENTERED RESEARCH IN METABOLIC DISEASE THROUGH INNOVATIVE TOOLS. We are delighted to announce our speaker line up and their talk titles Rajarshi Banerjee Perspectum Ltd Talk title: Understanding Cardiometabolic Disease with Multiorgan MRI @Benedicte Schutz Kapel Novo Nordisk A/S, University of Copenhagen (Københavns Universitet) Talk title: Decoding Cell-Type Specific Gene Regulation in Developing Metabolic Dysfunction-Associated Steatohepatitis Francisco R. Lopez Picon Novo Nordisk Talk title: Translational imaging in metabolic disease research and development @Zammy Fairhurst-hunter AstraZeneca Talk title: Rare-variant analysis identifies loss-of-function variants in BSN and APBA1 associated with severe obesity Christoffer Clemmensen University of Copenhagen (Københavns Universitet) Talk title: Translational studies in energy balance regulation Shawn Owens SpaceM Talk title: High Throughput Single-Cell Metabolomics Camilla Scheele University of Copenhagen (Københavns Universitet) Talk title: TBC FORUM PARTNER: DefiniGEN Scientific committee @Brigitte Andersen Ariel Feldstein Rupa Shree Appa-Pind Louise Strandberg Clemmensen Saleha Patel #drugdiscovery #ELRIG